Your browser doesn't support javascript.
loading
The Effect of Microwave and Radiofrequency Ablation (MWA/RFA) on Liver Volume in Patients with Primary and Secondary Liver Tumours: A Retrospective Analysis.
Knapen, Robrecht R M M; Korenblik, Remon; James, Sinead; Dams, Glenn; Olij, Bram; de Boer, Sanne W; van Dam, Ronald M; van der Leij, Christiaan.
Afiliación
  • Knapen RRMM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands. robrecht.knapen@mumc.nl.
  • Korenblik R; CARIM, School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands. robrecht.knapen@mumc.nl.
  • James S; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Dams G; GROW, School for Oncology and Reproduction, Maastricht, The Netherlands.
  • Olij B; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • de Boer SW; GROW, School for Oncology and Reproduction, Maastricht, The Netherlands.
  • van Dam RM; Department of Radiology and Nuclear Medicine, Zuyderland, Sittard, Heerlen, The Netherlands.
  • van der Leij C; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
Cardiovasc Intervent Radiol ; 46(8): 991-999, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37430014
ABSTRACT

PURPOSE:

It is known that thermal liver ablation can induce liver hypertrophy. However, exact impact in liver volume remains unclear. The aim of this study is to assess the influence of radiofrequency or microwave ablation (RFA/MWA) on liver volume in patients with primary and secondary liver lesions. Findings can be relevant in assessing the potential extra benefit of thermal liver ablation in preoperatively performed liver hypertrophy inducing procedures, such as portal vein embolization (PVE).

METHODS:

Between January 2014-May 2022, 69 invasive treatment naïve patients with primary (n = 43) or secondary/metastatic (n = 26) liver lesions (in all segments, except in segments II/III) treated percutaneously by RFA/MWA were included. Total liver volume (TLV), segment II + III volume (serving as "distant liver volume"), ablation zone volume and absolute liver volume (ALV, calculated by subtracting the ablation zone volume from the TLV) were the study outcomes.

RESULTS:

ALV in patients with secondary liver lesions increased to a median percentage of 106.87% (IQR = 99.66-113.03%, p = 0.016), volume of segments II/III increased to a median percentage of 105.81% (IQR = 100.06-115.65%, p = 0.003). ALV and segments II/III in patients with primary liver tumours remained stable, with a median percentage of 98.72% (IQR = 92.99-108.35%, p = 0.856) and 100.43% (IQR = 92.85-109.41%, p = 0.699), respectively.

CONCLUSION:

In patients with secondary liver tumours, ALV and segments II/III increased after MWA/RFA by an average of approximately 6%, while ALV in patients with primary liver lesions remained unchanged. Besides the curative intent, these findings indicate the potential added benefit of thermal liver ablation on FLR hypertrophy inducing procedures in patients with secondary liver lesions. LEVEL OF EVIDENCE Level 3, non-controlled retrospective cohort study.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ablación por Catéter / Ablación por Radiofrecuencia / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ablación por Catéter / Ablación por Radiofrecuencia / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos